All patients, n = 285 | Hospitalized patients (n = 92) | Nursing home residents (n = 93) | Assisted-living carehome residents (n = 100) | p value |
---|---|---|---|---|
1st GMAT Au/ml (95% CI) | 1307 (858–1992) | 5292 (3949–7093) | 10,398 (8085–13,373) | < 0.0001 |
2nd GMAT Au/ml (95% CI)a | NA | 3096 (2311–4148) | 3738 (2899–4822) | 0.68 |
Three-dose vaccine recipientsb | 41/92 (45%) | 70/93 (76%) | 91/100 (100%) | |
1st GMAT Au/ml (95% CI) post 3rd vaccine | n = 41 3794 (2279–6319) | n = 70 6096 (4466–8321) | n = 91 11,367 (8845–14,608) | < 0.001 |
2nd GMAT Au/ml (95% CI) post 3rd vaccinec | NA | n = 68/70 3280 (2390–4502) | n = 91/100 3661 (2840–4719) | 0.48 |